BSE filing, NSE: SHRINGARMS. Summary written from the filing by ALFA Finder's alert engine.
Shringar House of Mangalsutra Ltd: key numbers
- Share price
- ₹290.40
- Market cap
- ₹2,800 Cr
- Revenue (annual)
- ₹2,246 Cr
- Net profit (annual)
- ₹115.5 Cr
- P/E (TTM)
- 23.1×Sector 33.3×
- Promoter holding
- 74.80%+0.00% QoQ
- FII holding
- 3.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shringar House of Mangalsutra Ltd
All →Shringar House of Mangalsutra Results Update
Shringar House of Mangalsutra issued a press release on Q2 FY27 results, with revenue up 54.8% year on year. Profit after tax rose 73.2% in the quarter.
Shringar House of Mangalsutra Investor Presentation: Key Takeaways
H1 FY27 revenue ₹1,367 Cr (+58.7%), PAT ₹73.5 Cr (+43.1%), EBITDA margin 7.6%. Q2 FY27 revenue ₹819 Cr (+55%), PAT ₹39 Cr (+73%). Bridal jewellery entry; new 4,000 kg capacity.
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
Shringar House of Mangalsutra Q2 FY27 Results: Net Profit ₹39.5 Cr, Up 73.2% YoY
Shringar House of Mangalsutra approved unaudited standalone financial results for the quarter and half year ended September 30, 2026. The Board meeting concluded on November 4, 2026.
- Key figure
- Net profit ₹39.5 Cr · +73.2% YoY
Shringar House of Mangalsutra Board Meeting Date
Shringar House of Mangalsutra Ltd intimated a board meeting on 04 November 2026 to consider standalone unaudited financial results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results announcement.
Shringar House of Mangalsutra Price Movement Clarification
Shringar House of Mangalsutra clarified that it is in compliance with SEBI regulations and aware of no undisclosed material information affecting its share price movement.
Other other announcement announcements
All →Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.